Invea Therapeutics, Inc. (INAI)

Invea Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021
Cash & Equivalents	0.59	0.32
Cash & Cash Equivalents	0.59	0.32
Cash Growth	81.48%	-
Other Current Assets	0.19	0.07
Total Current Assets	0.78	0.39
Property, Plant & Equipment	0.01	0.01
Total Long-Term Assets	0.01	0.01
Total Assets	0.79	0.4
Accounts Payable	0.5	0.3
Current Debt	1.82	-
Other Current Liabilities	0.57	0.2
Total Current Liabilities	2.88	0.5
Long-Term Debt	-	1.16
Other Long-Term Liabilities	0.05	0
Total Long-Term Liabilities	0.05	1.16
Total Liabilities	2.93	1.66
Total Debt	1.82	1.16
Debt Growth	56.06%	-
Retained Earnings	-7.81	-2.05
Shareholders' Equity	-7.27	-1.86
Net Cash / Debt	-1.23	-0.84
Working Capital	-2.1	-0.11

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).